George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 25,000 shares at $43.85 ($1.1M) on 2022-11-10, disclosed to the SEC on 2022-11-14.
Open-market sale of $1.1M RPRX by EVP, Investments & CLO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |